CD63 and breast carcinoma: To study the exosomal miRNA from breast cancer, exosomes isolated from 231-CD63 were delivered into the recipient cells, RMF-EG After 48 h, the recipient cells were extracted using TRIzol reagents and analyzed using miRNA arrays.